ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1891

Excellent Reliability of Semiquantitative Nailfold Capillaroscopy Assessment in a Systemic Sclerosis Cohort – a Pilot Study

Ana Maria Gheorghiu, Raida Oneata, Alina Soare, Rucsandra Dobrota, Liviu Macovei, Mihaela Milicescu, Mariana Sasu, Marilena Gorga, Ioan Ancuta, Mihai Bojinca, Victor Stoica and Carina Mihai, Carol Davila University of Medicine and Pharmacy, Internal Medicine and Rheumatology Department, Cantacuzino Clinical Hospital, Bucharest, Romania

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Nailfold capillaroscopy (NFC) is essential in the evaluation and classification of systemic sclerosis (SSc). Semiquantitative capillaroscopy scoring is a promising tool for assessing disease activity, severity and change in SSc, however there is no consensus yet over which capillaroscopy abnormalities should be analyzed and how. We aimed to investigate the reliability of the qualitative and semiquantitative scoring of NFC assessment between two raters and test-retest for each rater in a SSc cohort.

Methods: This is a pilot study from one EUSTAR centre, where 2 raters assessed the NFC images of 48 consecutive patients with SSc. Data were analyzed in 3 ways: step 1. qualitatively by ‘normal’ / ‘abnormal’ category, step 2. ‘early’, ‘active’, ‘late’ scleroderma patterns and unclassifiable in any pattern, and step 3.semiquantitatively by calculating the mean score for capillary loss, disorganization of the microvasculat array, giant capillaries, microhaemorrhages and capillary ramifications; combinations of giant capillaries and microhaemorrhages (as a surrogate for vascular activity) and disorganization and ramifications (surrogate for vascular damage) were also assessed. Variables for all steps were calculated for all fingers and for each finger. Inter-rater/intrarater agreement was assessed by Cohen’s kappa coefficients for qualitative variables and by intraclass correlation coefficients (ICC) for mean score values of abnormalities. Differences in scores between patients with digital ulcers (DUs) history and Bosentan treatment were analyzed by logistic regression.

Results: Interrater reliability ranged from good to excellent agreement for mean score values of abnormalities in all fingers (ICC coefficients 0.745 to 0.897) and was excellent for activity (ICC coefficient of 0.923) and damage combinations (ICC coefficient of 0.918). Assessment of abnormalities in a qualitative manner (normal/abnormal or with capillaroscopy patterns) showed weaker interrater agreement than the semiquantitative assessment (k coefficient <0.7). When scores were assessed in each finger, interrater reliability was good to excellent for mean scores of abnormalities and activity and damage combinations (ICC coefficients 0.781 to 0.867 for mean abnormalities scores and 0.713 to 0.856 for combinations), whereas for qualitative assessments interrater reliability was much weaker (k coefficients <0.7). Intrarater variability was good to excellent for mean score values of abnormalities and activity and damage combinations in all fingers and separate fingers for both raters; for qualitative assessment only one of the raters had good test-retest reliability. There was no difference in scores between patients with/without DUs history or Bosentan treatment.

Conclusion: Reliability of NFC assessment is essential in SSc trials/clinical practice to ensure quality of data. This pilot study demonstrates very good reliability between raters of the semiquantitative NFC assessment in a SSc cohort. Combinations of capillaroscopy abnormalities had very good reliability and might be preferred because they are less time consuming. A longitudinal assessment and confirmation of our results in other cohorts is needed.


Disclosure: A. M. Gheorghiu, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2; R. Oneata, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2; A. Soare, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2; R. Dobrota, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2; L. Macovei, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2; M. Milicescu, None; M. Sasu, None; M. Gorga, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2; I. Ancuta, None; M. Bojinca, None; V. Stoica, None; C. Mihai, UEFIS-CDI PN-II-PT-PCCA-2013-4-1589 grant, 2.

To cite this abstract in AMA style:

Gheorghiu AM, Oneata R, Soare A, Dobrota R, Macovei L, Milicescu M, Sasu M, Gorga M, Ancuta I, Bojinca M, Stoica V, Mihai C. Excellent Reliability of Semiquantitative Nailfold Capillaroscopy Assessment in a Systemic Sclerosis Cohort – a Pilot Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/excellent-reliability-of-semiquantitative-nailfold-capillaroscopy-assessment-in-a-systemic-sclerosis-cohort-a-pilot-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/excellent-reliability-of-semiquantitative-nailfold-capillaroscopy-assessment-in-a-systemic-sclerosis-cohort-a-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology